.png){kind=icon}
.png){kind=icon}
Return
HIF-1α impairs NK cell differentiation-maturation and cytotoxicity in myelodysplastic syndrome via JAK1/STAT5/SOCS2 pathway
.png){kind=icon}
PRE
AI
W
L
W
T
C
DOI：10.1093/jimmun/vkag059.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Myelodysplastic syndrome (MDS) is a heterogeneous group of myeloid neoplasms characterized by treatment difficulties and a propensity to progress to acute myeloid leukemia. Impaired natural killer (NK) cell surveillance is a hallmark of MDS, yet the underlying molecular mechanisms remain poorly understood. This study aims to elucidate the mechanism by which HIF-1 alpha regulates NK cell differentiation disorders and its impact on NK cell cytotoxicity in MDS. Flow cytometry was employed to compare HIF-1 alpha expression and NK cell differentiation between wild-type and NUP98/HOXD13 (NHD13) mice. Our results demonstrated a significant increase in HIF-1 alpha expression in the bone marrow and peripheral blood of MDS mice, accompanied by a notable decrease in immature NK cell subsets and activating receptors (NKG2D, NKp44, and DNAM-1). Overexpression of HIF-1 alpha in human NK cells or pharmacological stabilization with CoCl2 inhibits the differentiation into mature NK cells, suppresses the expression of degranulation molecules such as Granzyme B, and impairs NK cell cytotoxicity. Western blot analysis indicated that HIF-1 alpha regulates NK cell differentiation and function via the JAK1/STAT5/SOCS2 signaling pathway. Collectively, these findings suggest that the hypoxic microenvironment in MDS enhances HIF-1 alpha expression, which subsequently impairs NK cell maturation and inhibits their cytotoxicity. Targeting HIF-1 alpha may delay MDS progression by enhancing NK cell function via the JAK1/STAT5/SOCS2 signaling pathway.
Keywords:
cell differentiation
HIF-1 alpha
JAK1/STAT5
myelodysplastic syndrome
natural killer cell
Journal
IF:
3.4
Papers:
3.7W
Citations:
9.9W
Organization
Cited Papers